Today (8Dec23): FDA approved Gene Editing for Sickle-Cell Anemia

Today (8Dec23): FDA approved Gene Editing for Sickle-Cell Anemia

The "DNA base editor" needed for this did not exist in nature. Instead, it needed to be evolved in the lab. Watch the outstanding talk, and explanation that tells you what needed to be done to cure this devastating condition:

https://www.youtube.com/watch?v=nmdhQsThLMM


Harish K. Vasishth

General Manager at "Akums Drugs and Pharmaceuticals Limited" CDMO Business | New Buss. Development | In-Out Licensing | Strategic Partnership | Exports - Strong hold on India, Africa, Asia, SEA, Latam and CIS countries

9 个月

Akums Drugs & Pharmaceuticals has innovated World's First room temperature stable Hydroxyurea Suspension, available at affordable price to the Patients suffering from Sickle Cell Disease. Akums' Hydroxyurea Suspension through the oral dose syringes can be administered to pediatric and adolescent patients at required dose based on their weight.

回复
Damian Toczyd?owski

Breaking The Code of Life — The Blueprint of Cellular (Epi)genomes ? Scientist, Epigeneticist & Geneticist ? I talk about Epigenomics & Functional Genomics

1 年

Thanks for sharing this piece, Ken Wasserman. Please take a moment to consider this one as well: Hofer, U. Phages keep bacteria awake. Nat Rev Microbiol20, 575 (2022). https://doi.org/10.1038/s41579-022-00781-2

回复

要查看或添加评论,请登录

Ken Wasserman的更多文章

社区洞察

其他会员也浏览了